title: Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C.
authors: Ozlen
authors: O
authors: Atug
authors: Hakan
authors: H
authors: Akin
authors: Yusuf
authors: Y
authors: Yilmaz
authors: Murat
authors: M
authors: Sari
authors: Nurdan
authors: N
authors: Tozun
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D001301:Audiometry, Pure-Tone; D004359:Drug Therapy, Combination; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced* / Q000175:diagnosis; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a